Observational studyClinical and experimental immunology2021

Intravenous immunoglobulin and the current risk of moderate and severe anaphylactic events, a cohort study.

Carlos Martinez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.